436 related articles for article (PubMed ID: 21812858)
1. Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis.
Uekita T; Sakai R
Cancer Sci; 2011 Nov; 102(11):1943-8. PubMed ID: 21812858
[TBL] [Abstract][Full Text] [Related]
2. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.
Miyazawa Y; Uekita T; Hiraoka N; Fujii S; Kosuge T; Kanai Y; Nojima Y; Sakai R
Cancer Res; 2010 Jun; 70(12):5136-46. PubMed ID: 20501830
[TBL] [Abstract][Full Text] [Related]
3. CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.
Uekita T; Jia L; Narisawa-Saito M; Yokota J; Kiyono T; Sakai R
Mol Cell Biol; 2007 Nov; 27(21):7649-60. PubMed ID: 17785447
[TBL] [Abstract][Full Text] [Related]
4. Effect of the tyrosine kinase inhibitor lapatinib on CUB-domain containing protein (CDCP1)-mediated breast cancer cell survival and migration.
Seidel J; Kunc K; Possinger K; Jehn C; Lüftner D
Biochem Biophys Res Commun; 2011 Oct; 414(1):226-32. PubMed ID: 21945930
[TBL] [Abstract][Full Text] [Related]
5. CUB-domain containing protein 1 represses the epithelial phenotype of pancreatic cancer cells.
Miura S; Hamada S; Masamune A; Satoh K; Shimosegawa T
Exp Cell Res; 2014 Feb; 321(2):209-18. PubMed ID: 24384474
[TBL] [Abstract][Full Text] [Related]
6. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
Hakomori S
Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
[TBL] [Abstract][Full Text] [Related]
7. CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma.
Uekita T; Tanaka M; Takigahira M; Miyazawa Y; Nakanishi Y; Kanai Y; Yanagihara K; Sakai R
Am J Pathol; 2008 Jun; 172(6):1729-39. PubMed ID: 18467693
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic Ras/ERK signaling activates CDCP1 to promote tumor invasion and metastasis.
Uekita T; Fujii S; Miyazawa Y; Iwakawa R; Narisawa-Saito M; Nakashima K; Tsuta K; Tsuda H; Kiyono T; Yokota J; Sakai R
Mol Cancer Res; 2014 Oct; 12(10):1449-59. PubMed ID: 24939643
[TBL] [Abstract][Full Text] [Related]
9. cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function.
Izzi L; Turbide C; Houde C; Kunath T; Beauchemin N
Oncogene; 1999 Sep; 18(40):5563-72. PubMed ID: 10523833
[TBL] [Abstract][Full Text] [Related]
10. Suppression of autophagy by CUB domain-containing protein 1 signaling is essential for anchorage-independent survival of lung cancer cells.
Uekita T; Fujii S; Miyazawa Y; Hashiguchi A; Abe H; Sakamoto M; Sakai R
Cancer Sci; 2013 Jul; 104(7):865-70. PubMed ID: 23510015
[TBL] [Abstract][Full Text] [Related]
11. In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.
Casar B; Rimann I; Kato H; Shattil SJ; Quigley JP; Deryugina EI
Oncogene; 2014 Jan; 33(2):255-68. PubMed ID: 23208492
[TBL] [Abstract][Full Text] [Related]
12. Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen.
Hooper JD; Zijlstra A; Aimes RT; Liang H; Claassen GF; Tarin D; Testa JE; Quigley JP
Oncogene; 2003 Mar; 22(12):1783-94. PubMed ID: 12660814
[TBL] [Abstract][Full Text] [Related]
13. CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases.
Leroy C; Shen Q; Strande V; Meyer R; McLaughlin ME; Lezan E; Bentires-Alj M; Voshol H; Bonenfant D; Alex Gaither L
Oncogene; 2015 Oct; 34(44):5593-8. PubMed ID: 25728678
[TBL] [Abstract][Full Text] [Related]
14. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
15. Targeting CUB domain-containing protein 1 with a monoclonal antibody inhibits metastasis in a prostate cancer model.
Siva AC; Wild MA; Kirkland RE; Nolan MJ; Lin B; Maruyama T; Yantiri-Wernimont F; Frederickson S; Bowdish KS; Xin H
Cancer Res; 2008 May; 68(10):3759-66. PubMed ID: 18483259
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of CDCP1 Expression in Colorectal Cancer and Effect of Its Inhibition on Invasion and Migration.
Chou CT; Li YJ; Chang CC; Yang CN; Li PS; Jeng YM; Chen ST; Kuo ML; Lin IC; Lin BR
Ann Surg Oncol; 2015 Dec; 22(13):4335-43. PubMed ID: 25820997
[TBL] [Abstract][Full Text] [Related]
17. A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo.
Jallal H; Valentino ML; Chen G; Boschelli F; Ali S; Rabbani SA
Cancer Res; 2007 Feb; 67(4):1580-8. PubMed ID: 17308097
[TBL] [Abstract][Full Text] [Related]
18. The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility.
Benes CH; Poulogiannis G; Cantley LC; Soltoff SP
Oncogene; 2012 Feb; 31(5):653-63. PubMed ID: 21725358
[TBL] [Abstract][Full Text] [Related]
19. CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment.
Law ME; Ferreira RB; Davis BJ; Higgins PJ; Kim JS; Castellano RK; Chen S; Luesch H; Law BK
Breast Cancer Res; 2016 Aug; 18(1):80. PubMed ID: 27495374
[TBL] [Abstract][Full Text] [Related]
20. Src signaling in cancer invasion.
Guarino M
J Cell Physiol; 2010 Apr; 223(1):14-26. PubMed ID: 20049846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
